AU2016294597B2 — Magnolia bark extract as a hydrophobic ligand for preferential removal of gram negative bacteria from the oral cavity
Assigned to WM Wrigley Jr Co · Expires 2021-10-14 · 5y expired
What this patent protects
The present disclosure relates generally to oral compositions and methods for freshening breath and oral cleansing, and more particularly, to oral compositions comprising a combination of an extract of magnolia and a hydrocarbon. The oral compositions are useful for improving ora…
USPTO Abstract
The present disclosure relates generally to oral compositions and methods for freshening breath and oral cleansing, and more particularly, to oral compositions comprising a combination of an extract of magnolia and a hydrocarbon. The oral compositions are useful for improving oral health, including freshening breath and reducing the adherence of plaque to teeth.
Drugs covered by this patent
- Cytarabine (Cytarabine) · Nippon Shinyaku Co., Ltd.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.